Kathleen M. Whalen is VP at HCA Healthcare, Inc. (HCA). They have made 15 open-market trades across 1 company since 2019, most recently 2024-11-14.
CIK 0001763910
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCA | 9,454 | $4.8M |
Shares reported on the most recent Form 4, priced at the 2024-11-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCA | SELL | 2024-11-14 | 2024-11-18 | $357.99 | $1.1M | -2.1% | -10.5% | -5.3% |
| HCA | SELL | 2024-07-29 | 2024-07-31 | $362.13 | $3.5M | -0.7% | +8.6% | -0.9% |
| HCA | SELL | 2024-05-16 | 2024-05-20 | $326.30 | $2.1M | +4.5% | +4.1% | +15.1% |
| HCA | SELL | 2024-02-09 | 2024-02-13 | $306.21 | $2.6M | +2.3% | +6.1% | +3.6% |
| HCA | SELL | 2023-08-03 | 2023-08-07 | $270.00 | $787K | -2.0% | +1.3% | -14.7% |
| HCA | SELL | 2023-02-17 | 2023-02-22 | $263.61 | $914K | -0.8% | +0.2% | +5.5% |
| HCA | SELL | 2022-05-03 | 2022-05-05 | $215.38 | $108K | -2.4% | -7.4% | -2.2% |
| HCA | SELL | 2021-11-04 | 2021-11-04 | $250.48 | $1.9M | -1.3% | -4.6% | -1.7% |
| HCA | SELL | 2021-07-22 | 2021-07-26 | $246.90 | $438K | +1.4% | +2.6% | -1.6% |
| HCA | SELL | 2021-02-04 | 2021-02-05 | $177.11 | $50K | -1.0% | +7.2% | +18.6% |
| HCA | SELL | 2020-10-29 | 2020-11-02 | $124.41 | $316K | +8.9% | +14.9% | +25.7% |
| HCA | SELL | 2020-02-07 | 2020-02-11 | $146.46 | $573K | -6.7% | -32.4% | -30.6% |
| HCA | SELL | 2019-11-04 | 2019-11-06 | $135.21 | $687K | +0.7% | +6.4% | +6.3% |
| HCA | SELL | 2019-08-13 | 2019-08-15 | $127.56 | $249K | -5.3% | +4.0% | +8.4% |
| HCA | SELL | 2019-02-06 | 2019-02-08 | $139.48 | $28K | +1.8% | -9.7% | -10.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.